Analyst Ratings for Ionis Pharmaceuticals (IONS) [Sells]

IONS Rating Summary

IONS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IONS
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $47.53 (+21.1%) * Over Last 12-Mos
Rating Score: 4.3 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/1/2022 Citi
» Updated 6/21/2022
David Lebowitz New Coverage Sell
(N/A)
26.00
(N/A)
31.78
(39.25)
23.51% Details
2/1/2022 BofA Securities Jason Gerberry Downgrade Underperform
(Buy)
30.00
(40.00)
31.80
(39.25)
23.43% Details
Like IONS Ratings? Also take a look at BIIB, BCYC, PFE, DOV

IONS Ratings News